Accelerating Process Development and Product Formulation.

Autor: Futran M; Pharmaceutical Engineering Solutions, LLC, Westfield, NJ, USA. mfutran@gmail.com., Muzzio F; Chemical and Biochemical Engineering, Rutgers University, Piscataway, NJ, USA., Chatterjee B; Pharmatech Associates - a USP Company, Hayward, CA, USA.
Jazyk: angličtina
Zdroj: Pharmaceutical research [Pharm Res] 2024 May; Vol. 41 (5), pp. 833-837. Date of Electronic Publication: 2024 May 02.
DOI: 10.1007/s11095-024-03708-z
Abstrakt: Currently, the lengthy time needed to bring new drugs to market or to implement postapproval changes causes multiple problems, such as delaying patients access to new lifesaving or life-enhancing medications and slowing the response to emergencies that require new treatments. However, new technologies are available that can help solve these problems. The January 2023 NIPTE pathfinding workshop on accelerating drug product development and approval included a session in which participants considered the current state of product formulation and process development, barriers to acceleration of the development timeline, and opportunities for overcoming these barriers using new technologies. The authors participated in this workshop, and in this article have shared their perspective of some of the ways forward, including advanced manufacturing techniques and adaptive development. In addition, there is a need for paradigm shifts in regulatory processes, increased pre-competitive collaboration, and a shared strategy among regulators, industry, and academia.
(© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz: